Marijke Amelink

1.9k total citations · 1 hit paper
18 papers, 1.3k citations indexed

About

Marijke Amelink is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Marijke Amelink has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 13 papers in Pulmonary and Respiratory Medicine and 2 papers in Immunology and Allergy. Recurrent topics in Marijke Amelink's work include Asthma and respiratory diseases (17 papers), Respiratory and Cough-Related Research (12 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Marijke Amelink is often cited by papers focused on Asthma and respiratory diseases (17 papers), Respiratory and Cough-Related Research (12 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Marijke Amelink collaborates with scholars based in Netherlands. Marijke Amelink's co-authors include Elisabeth H. Bel, Pieter‐Paul Hekking, Marcel L. Bouvy, Reinier Wener, A. H. Zwinderman, Anneke Ten Brinke, Selma B. de Nijs, Peter J. Sterk, Jantina C. de Groot and Aeilko H. Zwinderman and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, European Respiratory Journal and Allergy.

In The Last Decade

Marijke Amelink

16 papers receiving 1.3k citations

Hit Papers

The prevalence of severe refractory asthma 2014 2026 2018 2022 2014 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marijke Amelink Netherlands 13 1.1k 908 230 200 180 18 1.3k
G. F. Ryan Australia 7 743 0.6× 449 0.5× 162 0.7× 244 1.2× 75 0.4× 11 1.1k
Neil Martin United Kingdom 20 646 0.6× 581 0.6× 131 0.6× 125 0.6× 120 0.7× 62 1.0k
Leon M. van den Toorn Netherlands 15 626 0.5× 750 0.8× 119 0.5× 56 0.3× 83 0.5× 24 916
Adriana Carolei Italy 9 452 0.4× 350 0.4× 137 0.6× 24 0.1× 147 0.8× 26 1.2k
Christina Keen Sweden 13 965 0.8× 923 1.0× 126 0.5× 212 1.1× 69 0.4× 32 1.3k
Dilini Vethanayagam Canada 13 310 0.3× 260 0.3× 106 0.5× 95 0.5× 135 0.8× 36 622
Monica Cheng Munthe‐Kaas Norway 18 702 0.6× 608 0.7× 152 0.7× 200 1.0× 71 0.4× 34 1.1k
Marie‐Ève Boulay Canada 15 661 0.6× 435 0.5× 302 1.3× 108 0.5× 64 0.4× 51 838
Mark H. Moss United States 10 1.3k 1.2× 1.1k 1.3× 192 0.8× 74 0.4× 52 0.3× 24 1.5k
Pieter‐Paul Hekking Netherlands 5 622 0.5× 506 0.6× 109 0.5× 111 0.6× 85 0.5× 9 708

Countries citing papers authored by Marijke Amelink

Since Specialization
Citations

This map shows the geographic impact of Marijke Amelink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marijke Amelink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marijke Amelink more than expected).

Fields of papers citing papers by Marijke Amelink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marijke Amelink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marijke Amelink. The network helps show where Marijke Amelink may publish in the future.

Co-authorship network of co-authors of Marijke Amelink

This figure shows the co-authorship network connecting the top 25 collaborators of Marijke Amelink. A scholar is included among the top collaborators of Marijke Amelink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marijke Amelink. Marijke Amelink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Eger, Katrien, Marijke Amelink, Simone Hashimoto, et al.. (2021). Overuse of Oral Corticosteroids, Underuse of Inhaled Corticosteroids, and Implications for Biologic Therapy in Asthma. Respiration. 101(2). 116–121. 12 indexed citations
3.
Westerhof, Guus A., et al.. (2018). Diagnosing persistent blood eosinophilia in asthma with single blood eosinophil or exhaled nitric oxide level. Respiratory Medicine. 141. 81–86. 13 indexed citations
4.
Westerhof, Guus A., et al.. (2018). New-Onset Asthma in Adults: What Does the Trigger History Tell Us?. The Journal of Allergy and Clinical Immunology In Practice. 7(3). 898–905.e1. 12 indexed citations
5.
Hekking, Pieter‐Paul, Marijke Amelink, Reinier Wener, Marcel L. Bouvy, & Elisabeth H. Bel. (2017). Comorbidities in Difficult-to-Control Asthma. The Journal of Allergy and Clinical Immunology In Practice. 6(1). 108–113. 65 indexed citations
6.
Westerhof, Guus A., Jantina C. de Groot, Marijke Amelink, et al.. (2016). Predictors of frequent exacerbations in (ex)smoking and never smoking adults with severe asthma. Respiratory Medicine. 118. 122–127. 19 indexed citations
7.
Groot, Jantina C. de, Huib Storm, Marijke Amelink, et al.. (2016). Clinical profile of patients with adult-onset eosinophilic asthma. ERJ Open Research. 2(2). 100–2015. 86 indexed citations
8.
Westerhof, Guus A., Daniël A. Korevaar, Marijke Amelink, et al.. (2015). Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes. European Respiratory Journal. 46(3). 688–696. 118 indexed citations
9.
Amelink, Marijke, et al.. (2015). Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome. PA1045–PA1045. 2 indexed citations
10.
Amelink, Marijke, Simone Hashimoto, Philip Spinhoven, et al.. (2014). Anxiety, depression and personality traits in severe, prednisone-dependent asthma. Respiratory Medicine. 108(3). 438–444. 47 indexed citations
11.
Hekking, Pieter‐Paul, Reinier Wener, Marijke Amelink, et al.. (2014). The prevalence of severe refractory asthma. Journal of Allergy and Clinical Immunology. 135(4). 896–902. 544 indexed citations breakdown →
12.
Westerhof, Guus A., Daniël A. Korevaar, Marijke Amelink, et al.. (2014). Biomarkers for sputum eosinophilia in mild-moderate and severe adult-onset asthma patients. 44. 2053. 2 indexed citations
13.
Amelink, Marijke, Jantina C. de Groot, Selma B. de Nijs, et al.. (2013). Severe adult-onset asthma: A distinct phenotype. Journal of Allergy and Clinical Immunology. 132(2). 336–341. 152 indexed citations
14.
Amelink, Marijke, Selma B. de Nijs, Jan Cees de Groot, et al.. (2013). Three phenotypes of adult‐onset asthma. Allergy. 68(5). 674–680. 124 indexed citations
15.
Amelink, Marijke, Selma B. de Nijs, M Berger, et al.. (2012). Non‐atopic males with adult onset asthma are at risk of persistent airflow limitation. Clinical & Experimental Allergy. 42(5). 769–774. 24 indexed citations
16.
Majoor, Christof J., Pieter W. Kamphuisen, Aeilko H. Zwinderman, et al.. (2012). Risk of deep vein thrombosis and pulmonary embolism in asthma. European Respiratory Journal. 42(3). 655–661. 72 indexed citations
17.
Nijs, Selma B. de, Marijke Amelink, Frans H. Krouwels, et al.. (2012). Risk Factors Of Asthma Onset In Adulthood. A3968–A3968.
18.
Amelink, Marijke, S.M. Reinartz, W.J. Fokkens, et al.. (2011). Nasal Polyposis Identifies An At Risk Phenotype Among Patients With Adult-Onset Asthma. A3724–A3724. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026